Inventor · disambiguated record
George Vasmatzis
Also filed as: VASMATZIS GEORGE
14 granted patents·11 pending applications·150 citations·filing 1999–2023
91Inventor score
Files withMAYO FOUNDATION7MAYO FOUND MEDICAL EDUCATION & RES3US HEALTH3KLEE GEORGE G2TRANSLATIONAL GENOMICS RES INST2
Top patents by PatentIndex Score
25 records- 0194US7521054B2Reduction of the nonspecific animal toxicity of immunotoxins by mutating the framework regions of the Fv to lower the isoelectric pointUS HEALTH·Filed 2001·Granted Apr 21, 2009·72 cites·8 claims
- 0291US10494677B2Predicting cancer outcomeMAYO FOUND MEDICAL EDUCATION & RES·Filed 2016·Granted Dec 3, 2019·9 cites·4 claims
- 0388US11186875B2Targeted therapies for cancerTRANSLATIONAL GENOMICS RES INST·Filed 2016·Granted Nov 30, 2021·5 cites·15 claims
- 0488US9534249B2Predicting cancer outcomeMAYO FOUNDATION·Filed 2012·Granted Jan 3, 2017·9 cites·4 claims
- 0587US8273539B2Extracellular and membrane-associated prostate cancer markersKLEE GEORGE G·Filed 2007·Granted Sep 25, 2012·14 cites·3 claims
- 0686US8338109B2Predicting cancer outcomeVASMATZIS GEORGE·Filed 2007·Granted Dec 25, 2012·22 cites·3 claims
- 0782US7052703B1T-cell receptorγ alternate reading frame protein, (TARP) and uses thereofUS HEALTH·Filed 2000·Granted May 30, 2006·9 cites·31 claims
- 0881US8679743B2Reducing IRF4, DUSP22, or FLJ43663 polypeptide expressionFELDMAN ANDREW L·Filed 2011·Granted Mar 25, 2014·6 cites·3 claims
- 0976US2024253050A1Microchip high density hanging drop three-dimension culture platformUNIV ILLINOIS·Filed 2023·Application pending·0 cites
- 1069US11866789B2Targeted therapies for cancerTRANSLATIONAL GENOMICS RES INST·Filed 2021·Granted Jan 9, 2024·0 cites·26 claims
- 1166US11845084B2Microchip high density hanging drop three-dimension culture platformUNIV ILLINOIS·Filed 2021·Granted Dec 19, 2023·0 cites·19 claims
- 1261US2015024420A1Extracellular and membrane-associated prostate cancer markersMAYO FOUNDATION·Filed 2014·Application pending·0 cites
- 1358US2024343804A1Assessing and treating mesotheliomaMAYO FOUND MEDICAL EDUCATION & RES·Filed 2022·Application pending·0 cites
- 1456US8871451B2Extracellular and membrane-associated prostate cancer markersKLEE GEORGE G·Filed 2012·Granted Oct 28, 2014·0 cites·5 claims
- 1554US2007248972A1Page-4, an X-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses thereforGOV OF THE USA AS REPRESENTED·Filed 2007·Application pending·0 cites
- 1653US10203330B2Methods and materials for identifying and treating mammals having lung adenocarcinoma characterized by neuroendocrine differentiationMAYO FOUND MEDICAL EDUCATION & RES·Filed 2017·Granted Feb 12, 2019·0 cites·10 claims
- 1749US2010324119A1Reducing irf4, dusp22, or flj43663 polypeptide expressionMAYO FOUNDATION·Filed 2010·Application pending·0 cites
- 1849US2016018399A1Methods and materials for identifying and treating mammals having lung adenocarcinoma characterized by neuroendocrine differentiationMAYO FOUNDATION·Filed 2014·Application pending·0 cites
- 1948US2008119367A1Prognosis of Renal Cell CarcinomaMAYO FOUNDATION·Filed 2005·Application pending·0 cites
- 2044US7399827B1Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses thereforUS HEALTH·Filed 1999·Granted Jul 15, 2008·4 cites·11 claims
- 2144US2015191789A1Methods and materials for identifying mammals having prostate cancerMAYO FOUNDATION·Filed 2013·Application pending·0 cites
- 2239US9677137B2TBL1XR1 and TP63 translocationsMAYO FOUNDATION·Filed 2013·Granted Jun 13, 2017·0 cites·5 claims
- 2339US2003027178A1Methods and kits for determining a cancer diagnosis and prognosisFiled 2002·Application pending·0 cites
- 2439US2017022546A1Detection and quantification of methylation in dnaBASHIR RASHID·Filed 2015·Application pending·0 cites
- 2532US2013302808A1Predicting cancer outcomeVASMATZIS GEORGE·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →